Dr. Reddy’s Partners With Immutep For Cancer Drug Development And Commercialisation
Dr. Reddy’s Laboratories Ltd. has entered into a pact with Immutep Ltd. for the development and commercialisation of a cancer medication, Eftilagimod Alfa, in countries outside North America, Europe, Japan, and Greater China.